Suita, Japan

Masafumi Kitakaze



Average Co-Inventor Count = 6.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Masafumi Kitakaze: Innovator in Cardiac Monitoring and Treatment

Introduction

Masafumi Kitakaze is a notable inventor based in Suita, Japan. He has made significant contributions to the fields of cardiac monitoring and treatment, holding a total of 2 patents that reflect his innovative spirit and dedication to improving healthcare.

Latest Patents

One of his latest patents is a monitoring apparatus designed to assess the condition of the heart, lungs, and blood vessels. This apparatus utilizes a first sensor to measure the concentration of carbon dioxide in expired gas and a second sensor to evaluate an oxygen transport parameter or a metabolic parameter. Another significant invention is a prophylactic and/or therapeutic agent for cardiac infarction. This invention provides a novel drug aimed at preventing or treating myocardial infarction or myocardial ischemia-reperfusion injury, featuring a lipid membrane structure that retains adenosine.

Career Highlights

Throughout his career, Masafumi Kitakaze has worked with esteemed organizations such as the National Cerebral and Cardiovascular Center and Nihon Kohden Corporation. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking advancements in cardiac health.

Collaborations

Some of his notable coworkers include Masami Tanishima and Tatsuo Yoshida. Their collective efforts have furthered the development of innovative solutions in the medical field.

Conclusion

Masafumi Kitakaze's contributions to cardiac monitoring and treatment exemplify his commitment to innovation in healthcare. His patents and collaborations highlight the importance of research and development in improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…